Skip to main content

Table 5 Number of serious adverse events occurring during the intervention period coded by MedDRA

From: Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial

Preferred term Control n = 84 IF-BMOS n = 99 IF-BMOS + Pro n = 98 Breastfed n = 30
Pneumonia 3 2 1 1
Bronchitis 2 0 2 0
Apnoea 0 1 0 0
Dyspnoea 0 1 0 0
Upper respiratory tract infection 0 0 1 0
Abdominal pain 2 0 0 0
Gastroenteritis 2 0 0 0
Diarrhea 0 1 0 0
Gastroesophageal reflux 0 0 0 1
Stupor 1 0 0 0
Convulsions 0 0 1 0
Hernia inguinal 0 1 1 0
Sudden infant death syndrome 0 0 1 0
Urinary tract infection 0 0 1 0
Total 10 6 8 2
  1. MedDRA = Medical Dictionary for Regulatory Activities.